Patients regularly show up at university hospitals with diseases so rare and specific as to be scarcely known to physicians ...

Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been ...

The results from the statistical analysis suggest certain shared genes play a role in Alzheimer's, heart disease traits such ...

MERIDIAN — September is world Alzheimer's month and there is still no cure, but doctors say there are ways to protect ...

A common sleep medication could help reduce the buildup of harmful proteins in the brain linked to Alzheimer’s disease.

A new study has found a possible link between supine sleep — or sleeping on one's back — and neurodegenerative conditions ...

The study identifies lower potassium isotope ratios in Alzheimer's patients, suggesting δ41K as a viable biomarker for early ...

Nearly 7 million Americans have been diagnosed with dementia — Alzheimer's disease is the most common form of the syndrome.

In some people, new-onset depression may stem from the same buildup of toxic plaques in the brain that have long been linked ...

Sep. 5, 2024 — Research discovered a unique and promising avenue for diagnosing Alzheimer's disease (AD) earlier -- by analyzing AD biomarkers in blood -- so that the impacts of dementia can be ...

Higher nighttime light intensity is correlated with increased Alzheimer's disease prevalence, suggesting light pollution may ...

Research suggests light pollution may increase Alzheimer's risk, especially in those under 65. Reducing nighttime light ...